Microenvironmental regulation of telomerase isoforms in human embryonic stem cells

Stem Cells and Development

Volumn 23, Issue 17, 2014, Pages 2046-2066

  Radan, Lida ^a   Hughes, Chris S ^b   Teichroeb, Jonathan H ^a   Vieira Zamora, Flora M ^a   Jewer, Michael ^a   Postovit, Lynne Marie ^a,c   Betts, Dean Harvey ^a,c  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHIN; MESSENGER RNA; NEUROGENIC DIFFERENTIATION FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; OLIGONUCLEOTIDE PHOSPHOROTHIOATE; ORGANIC CATION TRANSPORTER 3; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TELOMERASE REVERSE TRANSCRIPTASE DELTA ALPHA; TELOMERASE REVERSE TRANSCRIPTASE DELTA ALPHA DELTA BETA; TELOMERASE REVERSE TRANSCRIPTASE DELTA BETA; TRANSCRIPTION FACTOR GATA 6; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG; ISOENZYME; OXYGEN; TERT PROTEIN, HUMAN;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL DIVISION; CELL FATE; CELL FUNCTION; CELL PROLIFERATION; CELL RENEWAL; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MICROENVIRONMENT; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; CELL HYPOXIA; CELL NUCLEUS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT;

ALTERNATIVE SPLICING; CELL DIFFERENTIATION; CELL HYPOXIA; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; ISOENZYMES; OXYGEN; PROTEIN TRANSPORT; TELOMERASE;

EID: 84906549484     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0373     Document Type: Article

References (108)

1. Ng HH and MA Surani. (2011). The transcriptional and signalling networks of pluripotency. Nat Cell Biol 13: 490-496.
2. Zeng X. (2007). Human embryonic stem cells: mechanisms to escape replicative senescence?. Stem Cell Rev 3:270-279.
3. Allshire RC, M Dempster and ND Hastie. (1989). Human telomeres contain at least three types of G-rich repeat distributed non-randomly. Nucleic Acids Res 17:4611-4627.
4. van Steensel B and T de Lange. (1997). Control of telomere length by the human telomeric protein TRF1. Nature 385:740-743.
5. Liu L, MA Blasco and DL Keefe. (2002). Requirement of functional telomeres for metaphase chromosome alignments and integrity of meiotic spindles. EMBO Rep 3: 230-234.
6. Rhyu MS. (1995). Telomeres, telomerase, and immortality. J Natl Cancer Inst 87:884-894.
7. Flores I, A Canela, E Vera, A Tejera, G Cotsarelis and MA Blasco. (2008). The longest telomeres: a general signature of adult stem cell compartments. Genes Dev 22:654-667.
8. Harley CB, H Vaziri, CM Counter and RC Allsopp. (1992). The telomere hypothesis of cellular aging. Exp Gerontol 27:375-382.
9. Greider CW and EH Blackburn. (1985). Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43:405-413.
10. Collins K, R Kobayashi and CW Greider. (1995). Purification of Tetrahymena telomerase and cloning of genes encoding the two protein components of the enzyme. Cell 81:677-686.
11. Kim NW, MA Piatyszek, KR Prowse, CB Harley, MD West, PL Ho, GM Coviello, WE Wright, SL Weinrich and JW Shay. (1994). Specific association of human telomerase activity with immortal cells and cancer. Science 266:2011-2015.
12. Wright WE, MA Piatyszek, WE Rainey, W Byrd and JW Shay. (1996). Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18:173-179.
13. Rudolph KL, S Chang, HW Lee, M Blasco, GJ Gottlieb, C Greider and RA DePinho. (1999). Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96:701-712.
14. Lee HW, MA Blasco, GJ Gottlieb, JW Horner 2nd, CW Greider and RA DePinho. (1998). Essential role of mouse telomerase in highly proliferative organs. Nature 392: 569-574.
15. Herrera E, AC Martinez and MA Blasco. (2000). Impaired germinal center reaction in mice with short telomeres. EMBO J 19:472-481.
16. Maciejewski JP and A Risitano. (2003). Hematopoietic stem cells in aplastic anemia. Arch Med Res 34:520-527.
17. Mason PJ, DB Wilson and M Bessler. (2005). Dyskeratosis congenita - a disease of dysfunctional telomere maintenance. Curr Mol Med 5:159-170.
18. Bodnar AG, M Ouellette, M Frolkis, SE Holt, CP Chiu, GB Morin, CB Harley, JW Shay, S Lichtsteiner and WE Wright. (1998). Extension of life-span by introduction of telomerase into normal human cells. Science 279:349-352.
19. Jaskelioff M, FL Muller, JH Paik, E Thomas, S Jiang, AC Adams, E Sahin, M Kost-Alimova, A Protopopov, et al. (2011). Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature 469:102-106.
20. Siegl-Cachedenier I, I Flores, P Klatt and MA Blasco. (2007). Telomerase reverses epidermal hair follicle stem cell defects and loss of long-term survival associated with critically short telomeres. J Cell Biol 179:277-290.
21. de Jesus BB, K Schneeberger, E Vera, A Tejera, CB Harley and MA Blasco. (2011). The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence. Aging Cell 10:604-621.
22. Flores I, ML Cayuela and MA Blasco. (2005). Effects of telomerase and telomere length on epidermal stem cell behavior. Science 309:1253-1256.
23. Cong Y and JW Shay. (2008). Actions of human telomerase beyond telomeres. Cell Res 18:725-732.
24. Choi J, LK Southworth, KY Sarin, AS Venteicher, W Ma, W Chang, P Cheung, S Jun, MK Artandi, et al. (2008). TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet 4:e10.
25. Park JI, AS Venteicher, JY Hong, J Choi, S Jun, M Shkreli, W Chang, Z Meng, P Cheung, et al. (2009). Telomerase modulates Wnt signalling by association with target gene chromatin. Nature 460:66-72.
26. Sarin KY, P Cheung, D Gilison, E Lee, RI Tennen, E Wang, MK Artandi, AE Oro and SE Artandi. (2005). Conditional telomerase induction causes proliferation of hair follicle stem cells. Nature 436:1048-1052.
27. Pucci F, L Gardano and L Harrington. (2013). Short telomeres in ESCs lead to unstable differentiation. Cell Stem Cell 12:479-486.
28. Shkreli M, KY Sarin, MF Pech, N Papeta, W Chang, SA Brockman, P Cheung, E Lee, F Kuhnert, et al. (2012). Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med 18:111-119.
29. Kilian A, DD Bowtell, HE Abud, GR Hime, DJ Venter, PK Keese, EL Duncan, RR Reddel and RA Jefferson. (1997). Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet 6:2011-2019.
30. Hrdlickova R, J Nehyba and HR Bose Jr. (2012). Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation. Mol Cell Biol 32:4283-4296.
31. Hisatomi H, K Ohyashiki, JH Ohyashiki, K Nagao, T Kanamaru, H Hirata, N Hibi and Y Tsukada. (2003). Expression profile of a gamma-deletion variant of the human telomerase reverse transcriptase gene. Neoplasia 5:193-197.
32. Saeboe-Larssen S, E Fossberg and G Gaudernack. (2006). Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues. BMC Mol Biol 7:26.
33. Yi X, DM White, DL Aisner, JA Baur, WE Wright and JW Shay. (2000). An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity. Neoplasia 2:433-440.
34. Colgin LM, C Wilkinson, A Englezou, A Kilian, MO Robinson and RR Reddel. (2000). The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2:426-432.
35. Ulaner GA, JF Hu, TH Vu, LC Giudice and AR Hoffman. (1998). Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts. Cancer Res 58:4168-4172.
36. Ulaner GA, JF Hu, TH Vu, LC Giudice and AR Hoffman. (2001). Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 91:644-649.
37. Brenner CA, YM Wolny, RR Adler and J Cohen. (1999). Alternative splicing of the telomerase catalytic subunit in human oocytes and embryos. Mol Hum Reprod 5:845-850.
38. Liu WJ, YW Zhang, ZX Zhang and J Ding. (2004). Alternative splicing of human telomerase reverse transcriptase may not be involved in telomerase regulation during all-trans-retinoic acid-induced HL-60 cell differentiation. J Pharmacol Sci 96:106-114.
39. Yi X, JW Shay and WE Wright. (2001). Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 29: 4818-4825.
40. Majerska J, E Sykorova and J Fajkus. (2011). Non-telomeric activities of telomerase. Mol Biosyst 7:1013-1023.
41. Chung HK, C Cheong, J Song and HW Lee. (2005). Extratelomeric functions of telomerase. Curr Mol Med 5:233-241.
42. Santos JH, JN Meyer and B Van Houten. (2006). Mitochondrial localization of telomerase as a determinant for hydrogen peroxide-induced mitochondrial DNA damage and apoptosis. Hum Mol Genet 15:1757-1768.
43. Passos JF, G Saretzki, S Ahmed, G Nelson, T Richter, H Peters, I Wappler, MJ Birket, G Harold, et al. (2007). Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol 5:e110.
44. Ahmed S, JF Passos, MJ Birket, T Beckmann, S Brings, H Peters, MA Birch-Machin, T von Zglinicki and G Saretzki. (2008). Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J Cell Sci 121:1046-1053.
45. Zhu H, W Fu and MP Mattson. (2000). The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis. J Neurochem 75:117-124.
46. Listerman I, J Sun, FS Gazzaniga, JL Lukas and EH Blackburn. (2013). The major reverse transcriptaseincompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis. Cancer Res 73:2817-2828.
47. Cao Y, H Li, S Deb and JP Liu. (2002). TERT regulates cell survival independent of telomerase enzymatic activity. Oncogene 21:3130-3138.
48. Perrault SD, PJ Hornsby and DH Betts. (2005). Global gene expression response to telomerase in bovine adrenocortical cells. Biochem Biophys Res Commun 335: 925-936.
49. Armstrong L, G Saretzki, H Peters, I Wappler, J Evans, N Hole, T von Zglinicki and M Lako. (2005). Overexpression of telomerase confers growth advantage, stress resistance, and enhanced differentiation of ESCs toward the hematopoietic lineage. Stem Cells 23:516-529.
50. Lee MK, MP Hande and K Sabapathy. (2005). Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J Cell Sci 118:819-829.
51. Yang C, S Przyborski, MJ Cooke, X Zhang, R Stewart, G Anyfantis, SP Atkinson, G Saretzki, L Armstrong and M Lako. (2008). A key role for telomerase reverse transcriptase unit in modulating human embryonic stem cell proliferation, cell cycle dynamics, and in vitro differentiation. Stem Cells 26:850-863.
52. Xu C, MS Inokuma, J Denham, K Golds, P Kundu, JD Gold and MK Carpenter. (2001). Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 19:971-974.
53. Johannes G and P Sarnow. (1998). Cap-independent polysomal association of natural mRNAs encoding c-myc, BiP, and eIF4G conferred by internal ribosome entry sites. RNA 4:1500-1513.
54. Mavrogiannou E, A Strati, A Stathopoulou, EG Tsaroucha, L Kaklamanis and ES Lianidou. (2007). Real-time RT-PCR quantification of human telomerase reverse transcriptase splice variants in tumor cell lines and nonsmall cell lung cancer. Clin Chem 53:53-61.
55. Seimiya H, T Oh-hara, T Suzuki, I Naasani, T Shimazaki, K Tsuchiya and T Tsuruo. (2002). Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991. Mol Cancer Ther 1:657-665.
56. Cohn EP, KL Wu, TR Pettus and NO Reich. (2012). A new strategy for detection and development of tractable telomerase inhibitors. J Med Chem 55:3678-3686.
57. Pitts AE and DR Corey. (1998). Inhibition of human telomerase by 2-O-methyl-RNA. Proc Natl Acad Sci U S A 95:11549-11554.
58. Topczewska JM, LM Postovit, NV Margaryan, A Sam, AR Hess, WW Wheaton, BJ Nickoloff, J Topczewski and MJ Hendrix. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nat Med 12:925-932.
59. Pfaffl MW. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45.
60. Simon MC and B Keith. (2008). The role of oxygen availability in embryonic development and stem cell function. Nat Rev Mol Cell Biol 9:285-296.
61. Dunwoodie SL. (2009). The role of hypoxia in development of the mammalian embryo. Dev Cell 17:755-773.
62. Lin CY, CY Peng, TT Huang, ML Wu, YL Lai, DH Peng, PF Chen, HF Chen, BL Yen, KK Wu and SF Yet. (2012). Exacerbation of oxidative stress-induced cell death and differentiation in induced pluripotent stem cells lacking heme oxygenase-1. Stem Cells Dev 21:1675-1687.
63. Postovit LM, NV Margaryan, EA Seftor, DA Kirschmann, A Lipavsky, WW Wheaton, DE Abbott, RE Seftor and MJ Hendrix. (2008). Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad Sci U S A 105: 4329-4334.
64. Hazeltine LB, JA Selekman and SP Palecek. (2013). Engineering the human pluripotent stem cell microenvironment to direct cell fate. Biotechnol Adv 31:1002-1019.
65. Mohyeldin A, T Garzon-Muvdi and A Quinones-Hinojosa. (2010). Oxygen in stem cell biology: a critical component of the stem cell niche. Cell Stem Cell 7:150-161.
66. Ezashi T, P Das and RM Roberts. (2005). Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A 102:4783-4788.
67. Forristal CE, KL Wright, NA Hanley, RO Oreffo and FD Houghton. (2010). Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions. Reproduction 139: 85-97.
68. Zachar V, SM Prasad, SC Weli, A Gabrielsen, K Petersen, MB Petersen and T Fink. (2010). The effect of human embryonic stem cells (hESCs) long-term normoxic and hypoxic cultures on the maintenance of pluripotency. In Vitro Cell Dev Biol Anim 46:276-283.
69. Chen HF, HC Kuo, SP Lin, CL Chien, MS Chiang and HN Ho. (2010). Hypoxic culture maintains self-renewal and enhances embryoid body formation of human embryonic stem cells. Tissue Eng Part A 16:2901-2913.
70. Mathieu J, Z Zhang, A Nelson, DA Lamba, TA Reh, C Ware and H Ruohola-Baker. (2013). Hypoxia induces reentry of committed cells into pluripotency. Stem Cells 31:1737-1748.
71. Yoshida Y, K Takahashi, K Okita, T Ichisaka and S Yamanaka. (2009). Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5:237-241.
72. Powers DE, JR Millman, RB Huang and CK Colton. (2008). Effects of oxygen on mouse embryonic stem cell growth, phenotype retention, and cellular energetics. Biotechnol Bioeng 101:241-254.
73. Ramirez MA, E Pericuesta, M Yanez-Mo, A Palasz and A Gutierrez-Adan. (2011). Effect of long-term culture of mouse embryonic stem cells under low oxygen concentration as well as on glycosaminoglycan hyaluronan on cell proliferation and differentiation. Cell Prolif 44: 75-85.
74. Chen HF, HC Kuo, W Chen, FC Wu, YS Yang and HN Ho. (2009). A reduced oxygen tension (5%) is not beneficial for maintaining human embryonic stem cells in the undifferentiated state with short splitting intervals. Hum Reprod 24:71-80.
75. Allegrucci C and LE Young. (2007). Differences between human embryonic stem cell lines. Hum Reprod Update 13:103-120.
76. Millman JR, JH Tan and CK Colton. (2009). The effects of low oxygen on self-renewal and differentiation of embryonic stem cells. Curr Opin Organ Transplant 14:694-700.
77. Fernandes TG, MM Diogo, A Fernandes-Platzgummer, CL da Silva and JM Cabral. (2010). Different stages of pluripotency determine distinct patterns of proliferation, metabolism, and lineage commitment of embryonic stem cells under hypoxia. Stem Cell Res 5:76-89.
78. Barbosa HS, TG Fernandes, TP Dias, MM Diogo and JM Cabral. (2012). New insights into the mechanisms of embryonic stem cell self-renewal under hypoxia: a multifactorial analysis approach. PLoS One 7:e38963.
79. Westfall SD, S Sachdev, P Das, LB Hearne, M Hannink, RM Roberts and T Ezashi. (2008). Identification of oxygen- sensitive transcriptional programs in human embryonic stem cells. Stem Cells Dev 17:869-881.
80. Forsyth NR, A Kay, K Hampson, A Downing, R Talbot and J McWhir. (2008). Transcriptome alterations due to physiological normoxic (2% O2) culture of human embryonic stem cells. Regen Med 3:817-833.
81. Coussens M, P Davy, L Brown, C Foster, WH Andrews, M Nagata and R Allsopp. (2010). RNAi screen for telomerase reverse transcriptase transcriptional regulators identifies HIF1alpha as critical for telomerase function in murine embryonic stem cells. Proc Natl Acad Sci U S A 107:13842-13847.
82. Nishi H, T Nakada, S Kyo, M Inoue, JW Shay and K Isaka. (2004). Hypoxia-inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 24:6076-6083.
83. Anderson CJ, SF Hoare, M Ashcroft, AE Bilsland and WN Keith. (2006). Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene 25:61-69.
84. Yu RM, EX Chen, RY Kong, PK Ng, HO Mok and DW Au. (2006). Hypoxia induces telomerase reverse transcriptase (TERT) gene expression in non-tumor fish tissues in vivo: the marine medaka (Oryzias melastigma) model. BMC Mol Biol 7:27.
85. Minamino T, SA Mitsialis and S Kourembanas. (2001). Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 21: 3336-3342.
86. Haendeler J, J Hoffmann, JF Diehl, M Vasa, I Spyridopoulos, AM Zeiher and S Dimmeler. (2004). Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 94:768-775.
87. Haendeler J, J Hoffmann, RP Brandes, AM Zeiher and S Dimmeler. (2003). Hydrogen peroxide triggers nuclear export of telomerase reverse transcriptase via Src kinase family-dependent phosphorylation of tyrosine 707. Mol Cell Biol 23:4598-4610.
88. Haendeler J, S Drose, N Buchner, S Jakob, J Altschmied, C Goy, I Spyridopoulos, AM Zeiher, U Brandt and S Dimmeler. (2009). Mitochondrial telomerase reverse transcriptase binds to and protects mitochondrial DNA and function from damage. Arterioscler Thromb Vasc Biol 29:929-935.
89. Hirashima K, T Migita, S Sato, Y Muramatsu, Y Ishikawa and H Seimiya. (2013). Telomere length influences cancer cell differentiation in vivo. Mol Cell Biol 33:2988-2995.
90. Smogorzewska A and T de Lange. (2004). Regulation of telomerase by telomeric proteins. Annu Rev Biochem 73:177-208.
91. Wong VC, J Ma and CE Hawkins. (2009). Telomerase inhibition induces acute ATM-dependent growth arrest in human astrocytomas. Cancer Lett 274:151-159.
92. Kim HS, MJ Quon and JA Kim. (2014). New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol 2:187-195.
93. Mata JE, SS Joshi, B Palen, SJ Pirruccello, JD Jackson, N Elias, TJ Page, KL Medlin and PL Iversen. (1997). A hexameric phosphorothioate oligonucleotide telomerase inhibitor arrests growth of Burkitt's lymphoma cells in vitro and in vivo. Toxicol Appl Pharmacol 144:189-197.
94. Chepelev I and X Chen. (2013). Alternative splicing switching in stem cell lineages. Front Biol (Beijing) 8:50-59.
95. Liu H, L He and L Tang. (2012). Alternative splicing regulation and cell lineage differentiation. Curr Stem Cell Res Ther 7:400-406.
96. Venables JP. (2006). Unbalanced alternative splicing and its significance in cancer. Bioessays 28:378-386.
97. Sykorova E and J Fajkus. (2009). Structure-function relationships in telomerase genes. Biol Cell 101:375-392; 1 p following 392.
98. Amor S, S Remy, G Dambrine, Y Le Vern, D Rasschaert and S Laurent. (2010). Alternative splicing and nonsensemediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo. BMC Cancer 10:571.
99. Wong MS, L Chen, C Foster, R Kainthla, JW Shay and WE Wright. (2013). Regulation of telomerase alternative splicing: a target for chemotherapy. Cell Rep 3:1028-1035.
100. Wang Y, AK Meeker, J Kowalski, HL Tsai, H Somervell, C Heaphy, LE Sangenario, N Prasad, WH Westra, MA Zeiger and CB Umbricht. (2011). Telomere length is related to alternative splice patterns of telomerase in thyroid tumors. Am J Pathol 179:1415-1424.
101. Zhu S, P Rousseau, C Lauzon, V Gandin, I Topisirovic and C Autexier. (2014). Inactive C-terminal telomerase reverse transcriptase insertion splicing variants are dominant-negative inhibitors of telomerase. Biochimie 101: 93-103.
102. Wu YL, C Dudognon, E Nguyen, J Hillion, F Pendino, I Tarkanyi, J Aradi, M Lanotte, JH Tong, GQ Chen and E Segal-Bendirdjian. (2006). Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 119:2797-2806.
103. Morcos PA. (2007). Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos. Biochem Biophys Res Commun 358:521-527.
104. Schmajuk G, H Sierakowska and R Kole. (1999). Antisense oligonucleotides with different backbones. Modification of splicing pathways and efficacy of uptake. J Biol Chem 274:21783-21789.
105. Gebski BL, CJ Mann, S Fletcher and SD Wilton. (2003). Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle. Hum Mol Genet 12:1801-1811.
106. Brambilla C, M Folini, P Gandellini, L Daprai, MG Daidone and N Zaffaroni. (2004). Oligomer-mediated modulation of hTERT alternative splicing induces telomerase inhibition and cell growth decline in human prostate cancer cells. Cell Mol Life Sci 61:1764-1774.
107. Mazumdar J, WT O'Brien, RS Johnson, JC LaManna, JC Chavez, PS Klein and MC Simon. (2010). O2 regulates stem cells through Wnt/beta-catenin signalling. Nat Cell Biol 12:1007-1013.
108. Bojesen SE, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, SL Edwards, HA Pickett, HC Shen, et al. (2013). Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet 45:371-384, 384e1-384e2.